Healthcare -
Biotechnology - NASDAQ - US
$ 1.5049
13.2 %
$ 106 M
Market Cap
-2.25
P/E
SLS - OPERATING EXPENSES
Operating Expenses SLS - SELLAS Life Sciences Group, Inc.
37.9 M
LAST VALUE
7.62%
2 YEAR CAGR
4.02%
5 YEAR CAGR
0.56%
10 YEAR CAGR